narcolepsy

Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep
Biotech

Chasing Takeda, Alkermes reports phase 2 narcolepsy win

Alkermes has reported a midphase win in narcolepsy type 1, keeping up the pressure on Takeda’s near-approval rival for the blockbuster opportunity.
Nick Paul Taylor Jul 21, 2025 8:40am
Arrows hitting targets

Takeda narcolepsy blockbuster hopeful secures double ph. 3 wins

Jul 14, 2025 5:51am
Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep

Alkermes impresses in full-throttle narcolepsy race with Takeda

Jun 4, 2024 9:01am
Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep

Phase 2b narcolepsy win powers Takeda toward pivotal trials

Feb 9, 2024 6:02am
Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep

Jazz halts sleep disorder med trial over 'visual disturbances'

Nov 29, 2023 10:50am
Takeda HQ

Takeda cuts ties to cancer drug landed in $120M Turnstone deal

Jul 28, 2022 7:00am